US75120L1008 - Common Stock
Which stocks are moving on Monday?
Today's session on Monday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
Friday's session: top gainers and losers
Unusual volume stocks are being observed in Friday's session.
Let's have a look at the gap up and gap down stocks in today's session.
Stay updated with the stocks that are on the move in Friday's pre-market session.
Friday is here and we're starting the final day of trading this week with a breakdown of the biggest pre-market stock movers this morning!
Top movers analysis one hour before the close of the markets on 2024-04-11: top gainers and losers in today's session.
These stocks are the most active in today's session
Curious to know what's happening on the US markets in the middle of the day on Thursday? Join us as we explore the top gainers and losers in today's session.
Thursday's session: gap up and gap down stocks
Hub Cyber Security stock is falling on Thursday after the company noted an investor sold a large stake of its HUBC shares.
Thursday's pre-market session: top gainers and losers
Aptevo Therapeutics stock is falling on Thursday after the company priced a public offering for 3.4 million shares of APVO.
Shares of Rallybio Corporation (NASDAQ: RLYB) rose sharply in today’s pre-market trading after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant individuals at risk of FNAIT.
Rent the Runway stock is on the rise Thursday as investors in the company celebrate strong revenue in its most recent earnings report.
Rallybio stock is rocketing higher on Thursday with heavy trading of RLYB shares after announcing a collaboration with Johnson & Johnson.
We're starting off Thursday with a breakdown of all the biggest pre-market stock movers traders will want to keep an eye on this morning!
Top movers in Wednesday's after hours session
Jefferies has downgraded Rallybio (RLYB) to hold, citing a lack of near-term pipeline catalysts and slow development of its lead drug program.
Rallybio (RLYB) shares rose 13% early Tuesday after the company announced it was cutting 45% of its workforce to streamline its drug portfolio and extend its ca